195 related articles for article (PubMed ID: 31681335)
1. Expression of CD39 Is Correlated With HIV DNA Levels in Naïve Tregs in Chronically Infected ART Naïve Patients.
Song JW; Huang HH; Zhang C; Yang HG; Zhang JY; Xu RN; Jin L; Shi M; Wang FS; Jiao YM
Front Immunol; 2019; 10():2465. PubMed ID: 31681335
[No Abstract] [Full Text] [Related]
2. Natural naive CD4+CD25+CD127low regulatory T cell (Treg) development and function are disturbed in multiple sclerosis patients: recovery of memory Treg homeostasis during disease progression.
Venken K; Hellings N; Broekmans T; Hensen K; Rummens JL; Stinissen P
J Immunol; 2008 May; 180(9):6411-20. PubMed ID: 18424765
[TBL] [Abstract][Full Text] [Related]
3. Dynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection.
Yero A; Shi T; Farnos O; Routy JP; Tremblay C; Durand M; Tsoukas C; Costiniuk CT; Jenabian MA
EBioMedicine; 2021 Sep; 71():103570. PubMed ID: 34500304
[TBL] [Abstract][Full Text] [Related]
4. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
[TBL] [Abstract][Full Text] [Related]
5. Human antigen-specific CD4⁺ CD25⁺ CD134⁺ CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses.
Seddiki N; Cook L; Hsu DC; Phetsouphanh C; Brown K; Xu Y; Kerr SJ; Cooper DA; Munier CM; Pett S; Ananworanich J; Zaunders J; Kelleher AD
Eur J Immunol; 2014 Jun; 44(6):1644-61. PubMed ID: 24752698
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease.
Schulze Zur Wiesch J; Thomssen A; Hartjen P; Tóth I; Lehmann C; Meyer-Olson D; Colberg K; Frerk S; Babikir D; Schmiedel S; Degen O; Mauss S; Rockstroh J; Staszewski S; Khaykin P; Strasak A; Lohse AW; Fätkenheuer G; Hauber J; van Lunzen J
J Virol; 2011 Feb; 85(3):1287-97. PubMed ID: 21047964
[TBL] [Abstract][Full Text] [Related]
7. CD8
Fenoglio D; Dentone C; Signori A; Di Biagio A; Parodi A; Kalli F; Nasi G; Curto M; Cenderello G; De Leo P; Bartolacci V; Orofino G; Nicolini LA; Taramasso L; Fiorillo E; Orrù V; Traverso P; Bruzzone B; Ivaldi F; Mantia E; Guerra M; Negrini S; Giacomini M; Bhagani S; Filaci G
J Allergy Clin Immunol; 2018 Jun; 141(6):2220-2233.e4. PubMed ID: 29103633
[TBL] [Abstract][Full Text] [Related]
8. Reversal of the CD8
Li J; Huang HH; Tu B; Zhou MJ; Hu W; Fu YL; Li XY; Yang T; Song JW; Fan X; Jiao YM; Xu RN; Zhang JY; Zhou CB; Yuan JH; Zhen C; Shi M; Wang FS; Zhang C
Front Immunol; 2021; 12():687296. PubMed ID: 34177939
[TBL] [Abstract][Full Text] [Related]
9. CD39/adenosine pathway is involved in AIDS progression.
Nikolova M; Carriere M; Jenabian MA; Limou S; Younas M; Kök A; Huë S; Seddiki N; Hulin A; Delaneau O; Schuitemaker H; Herbeck JT; Mullins JI; Muhtarova M; Bensussan A; Zagury JF; Lelievre JD; Lévy Y
PLoS Pathog; 2011 Jul; 7(7):e1002110. PubMed ID: 21750674
[TBL] [Abstract][Full Text] [Related]
10. Regulatory T cells negatively affect IL-2 production of effector T cells through CD39/adenosine pathway in HIV infection.
Jenabian MA; Seddiki N; Yatim A; Carriere M; Hulin A; Younas M; Ghadimi E; Kök A; Routy JP; Tremblay A; Sévigny J; Lelievre JD; Levy Y
PLoS Pathog; 2013; 9(4):e1003319. PubMed ID: 23658513
[TBL] [Abstract][Full Text] [Related]
11. TCR usage, gene expression and function of two distinct FOXP3(+)Treg subsets within CD4(+)CD25(hi) T cells identified by expression of CD39 and CD45RO.
Ye L; Goodall JC; Zhang L; Putintseva EV; Lam B; Jiang L; Liu W; Yin J; Lin L; Li T; Wu X; Yeo G; Shugay M; Chudakov DM; Gaston H; Xu H
Immunol Cell Biol; 2016 Mar; 94(3):293-305. PubMed ID: 26467610
[TBL] [Abstract][Full Text] [Related]
12. Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection.
Tang Y; Jiang L; Zheng Y; Ni B; Wu Y
BMC Immunol; 2012 Apr; 13():17. PubMed ID: 22489829
[TBL] [Abstract][Full Text] [Related]
13. CD39 expression on Treg and Th17 cells is associated with metabolic factors in patients with type 2 diabetes.
Cortez-Espinosa N; Cortés-Garcia JD; Martínez-Leija E; Rodríguez-Rivera JG; Barajas-López C; González-Amaro R; Portales-Pérez DP
Hum Immunol; 2015 Sep; 76(9):622-30. PubMed ID: 26386144
[TBL] [Abstract][Full Text] [Related]
14. Helios+ and Helios- cells coexist within the natural FOXP3+ T regulatory cell subset in humans.
Himmel ME; MacDonald KG; Garcia RV; Steiner TS; Levings MK
J Immunol; 2013 Mar; 190(5):2001-8. PubMed ID: 23359504
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic characterization of regulatory T cells from antiretroviral-naive HIV-1-infected people.
Ambada GN; Ntsama CE; Nji NN; Ngu LN; Sake CN; Lissom A; Tchouangeu FT; Tchadji J; Sosso M; Etoa FX; Nchinda GW
Immunology; 2017 Aug; 151(4):405-416. PubMed ID: 28375551
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of CD4
McRae JL; Chia JS; Pommey SA; Dwyer KM
Nephrology (Carlton); 2017 Jul; 22(7):505-512. PubMed ID: 27517975
[TBL] [Abstract][Full Text] [Related]
17. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
18. CD39
Shen M; Lim JME; Chia C; Ren EC
Immunobiology; 2020 Jan; 225(1):151868. PubMed ID: 31784043
[TBL] [Abstract][Full Text] [Related]
19. CD39+ regulatory T cells attenuate allergic airway inflammation.
Li P; Gao Y; Cao J; Wang W; Chen Y; Zhang G; Robson SC; Wu Y; Yang J
Clin Exp Allergy; 2015 Jun; 45(6):1126-37. PubMed ID: 25728362
[TBL] [Abstract][Full Text] [Related]
20. The abnormal function of CD39
Lu Y; Cheng L; Li F; Ji L; Shao X; Wu B; Zhan Y; Liu C; Min Z; Ke Y; Sun L; Chen H; Cheng Y
Ann Hematol; 2019 Aug; 98(8):1845-1854. PubMed ID: 31154474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
